Feedback PLC Bleepa to join DIT's first virtual event to India
04 Dicembre 2020 - 8:00AM
RNS Non-Regulatory
TIDMFDBK
Feedback PLC
04 December 2020
Reach
Feedback plc
Bleepa selected for Department for International Trade India
Healthcare Virtual Mission
-- The India Healthcare Virtual Mission - 8-10 December
-- India's healthcare market projected to grow to $372 billion by 2022
-- Event enables engagement with key stakeholders and
influencers in India's Healthcare industry
London, 4 December 2020: Feedback plc (AIM: FDBK, "Feedback" or
the "Company"), the specialist medical imaging technology company,
today announces that Bleepa has been selected by Healthcare UK,
part of the Department for International Trade ("DIT"), to join a
virtual healthcare mission to India, 8-10 December 2020.
DIT - India Healthcare Virtual Mission
This is the DIT's first virtual event to India, building on the
success of trade delegations visiting India over the last four
years. Leading British healthcare innovators in artificial
intelligence in healthcare, digital health, smart diagnostics and
home-care technology, for both the Covid and post-Covid world, are
selected to join this mission, led by the Chairman of NHS England,
Lord David Prior.
Innovation in healthcare delivery is a key priority for
healthcare providers in India, as India's healthcare market is
projected to grow to USD 372bn by 2022(1) . The event offers the
chance to interact with key stakeholders and influencers from the
Indian healthcare industry, including high-profile speakers from
reputed organisations on key issues/opportunities in the industry
from both UK and India. Companies joining the mission will receive
dedicated support from the DIT network.
Dr Tom Oakley, CEO of Feedback, commented:
"There are a number of potential opportunities for Bleepa within
the large and growing Indian healthcare market such as with the
newly announced National Digital Health Mission, which targets
giving every Indian citizen a unique health ID and digitized health
records.
"Bleepa has the ability to support the hub and spoke hospital
system in India. With a population of 1.38 billion people, access
to centres of excellence in the four major cities is not possible
for all, with both capacity and funding limiting access to top tier
treatment. We believe that Bleepa can provide the vital digital
link between these centres of excellence and regional or even
mobile care units, enabling millions more patients to receive the
high standards of care targeted in the National Digital Health
Mission.
"We believe that Bleepa's digital modular capabilities as a CE
marked communications platform would make Bleepa an attractive
option for the Indian market. We look forward to scoping the
opportunities available with the support of Healthcare UK and
DIT."
1. https://www.events.great.gov.uk/ehome/index.php?eventid=200212218&
-Ends-
Enquiries:
Feedback plc +44 (0)1954 718072
Tom Oakley, CEO IR@fbk.com
Lindsay Melvin, CFO
Allenby Capital Limited (Nominated
Adviser)
David Worlidge / Asha Chotai +44 (0)20 3328 5656
Walbrook PR Ltd Tel: 020 7933 8780 or feedbackplc@walbrookpr.com
Paul McManus/Nick Rome/Nicholas 07980 541 893 or 07748 325 236 or
Johnson 07884 664 686
Notes to Editors
Feedback plc (AIM: FDBK) is a medical imaging technology
business. Its core product, Bleepa, is a revolutionary medical
imaging communications app, providing an easy-to-use, high quality
tool to enable remote and secure communications between front-line
clinicians and teams. Importantly, it is the only CE marked medical
imaging communications platform on the NHSx clinical communications
tools framework. Bleepa has unparalleled functionality for everyday
practice and can be accessed from any internet-connected device,
enabling control of patient cases when on the go.
Its highly scalable Software as a Service ("SaaS") based revenue
model will provide increasing levels of visibility as the Company
grows its customer base. With a growing distribution base and
technology in place, the focus is on leveraging key relationships
in order to drive sales both in the UK and internationally to all
forms of care facilitators. As a fully certified medical device,
Bleepa aims to disrupt the medical imaging communications market
and, importantly, increase the accuracy and speed of diagnosis.
About Department for International Trade
The Department for International Trade (DIT) helps businesses
export and grow into global markets. We also help overseas
companies locate and grow in the UK. Our services are provided in
over 100 markets throughout the world. We are passionate about what
we do. That's why we constantly review our services in light of
customer feedback and the impact they offer, which means they'll
vary from time to time.
https://www.gov.uk/government/organisations/department-for-international-trade/about-our-services
About RNS Reach announcements
This is an RNS Reach announcement. RNS Reach is an investor
communication service aimed at assisting listed and unlisted
(including AIM quoted) companies to distribute media only /
non-regulatory news releases into the public domain. Information
required to be notified under the AIM Rules for Companies, Market
Abuse Regulation or other regulation would be disseminated as an
RNS regulatory announcement and not on RNS Reach.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAUORWRRVUURAA
(END) Dow Jones Newswires
December 04, 2020 02:00 ET (07:00 GMT)
Grafico Azioni Feedback (LSE:FDBK)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Feedback (LSE:FDBK)
Storico
Da Apr 2023 a Apr 2024